triple acting glp 1 Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor agonist History of glucagon-like peptide-1 receptor
Description
+ This pairing creates a more complete amino acid profile
FDA Regulatory Notice: As of February 2026, the FDA has resolved the semaglutide drug shortage and has stated its intent to prioritize enforcement against certain mass-marketed non-FDA-approved GLP-1 products
A 2025 study concluded that GLP-1 drugs can help improve heart and brain health but might also cause kidney and gastrointestinal issues
Where does the value come from
For so long people who couldnt lose weight and keep it off have been told that their willpower simply wasnt strong enough, says Daniel Drucker, an endocrinologist at the University of Toronto, who researched GLP-1 alongside Mojsov in the 1990s
But just to kind of keep us on the, topic of coverage, Im gonna, Suzanne, ask you to maybe, talk through, the next couple slides a little bit
